diclofenac has been researched along with Uveitis in 14 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 9.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 7.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "We studied if tobramycin associated to sodium diclofenac modifies the drug effect of the latter on arachidonic acid metabolism in an endotoxin induced uveitis (EIU) model in albino rabbits." | 7.71 | [Effect of tobramycin with topical diclofenac on arachidonic acid in endotoxin-induced uveitis]. ( Alió y Sanz, J; Honrubia López, FM; Ruiz Moreno, JM; Ruiz Moreno, O; Vélez, P, 2001) |
| "Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis." | 6.41 | Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000) |
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 5.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 3.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "We studied if tobramycin associated to sodium diclofenac modifies the drug effect of the latter on arachidonic acid metabolism in an endotoxin induced uveitis (EIU) model in albino rabbits." | 3.71 | [Effect of tobramycin with topical diclofenac on arachidonic acid in endotoxin-induced uveitis]. ( Alió y Sanz, J; Honrubia López, FM; Ruiz Moreno, JM; Ruiz Moreno, O; Vélez, P, 2001) |
| " Indomethacin (IM) enhanced TNF production in all the eight TCC that were established from a patient with human T lymphotrophic virus type 1 uveitis or pulmonary sarcoidosis, and suppressed IL-6 production in six of the eight TCC, without affecting their low levels of PGE2 production." | 3.69 | Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production. ( Itoh, K; Nakao, M; Shichijo, S; Tanaka, H; Tsuboi, I, 1995) |
| "Initial angiographic cystoid macular edema was comparable and significantly improved after therapy in the two treatment groups." | 2.67 | [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema]. ( Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P, 1992) |
| "Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear pathogenesis." | 2.41 | Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review. ( Acquaviva, PC; Bernard, P; Dahan, L; Daumen-Legré, V; Lafforgue, P; Pham, T; Rey, J, 2000) |
| "Eyes treated with ketorolac and diclofenac demonstrated reduced aqueous leucocyte concentrations of 62% and 64% respectively, compared with untreated controls (p<0." | 1.35 | Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation. ( Barañano, DE; Durairaj, C; Edelhauser, HF; Handa, JT; Kim, SJ; Kompella, UB, 2009) |
| "Diclofenac levels were measured by HPLC in the cornea, aqueous humor (AH), iris/ciliary body (ICB) and plasma 30 min, 1, 3, 6 and 12 h after application." | 1.30 | The ocular pharmacokinetics of topical diclofenac is affected by ocular inflammation. ( Alcoriza, N; Bellot, JL; García-Cabanes, C; Orts, A; Palmero, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kianersi, F | 1 |
| Rezaeian-Ramsheh, A | 1 |
| Pourazizi, M | 1 |
| Kianersi, H | 1 |
| Soheilian, M | 1 |
| Eskandari, A | 1 |
| Ramezani, A | 1 |
| Rabbanikhah, Z | 1 |
| Soheilian, R | 1 |
| Barañano, DE | 1 |
| Kim, SJ | 1 |
| Edelhauser, HF | 1 |
| Durairaj, C | 1 |
| Kompella, UB | 1 |
| Handa, JT | 1 |
| Kobayashi, S | 1 |
| Tamura, N | 1 |
| Ikeda, M | 1 |
| Sakuraba, K | 1 |
| Matsumoto, T | 1 |
| Hashimoto, H | 1 |
| Agata, M | 1 |
| Abe, T | 1 |
| Kon, M | 1 |
| Tanaka, M | 1 |
| Kimura, T | 1 |
| Nakajima, A | 1 |
| Herbort, CP | 2 |
| Tsuboi, I | 1 |
| Tanaka, H | 1 |
| Nakao, M | 1 |
| Shichijo, S | 1 |
| Itoh, K | 1 |
| Bellot, JL | 2 |
| Palmero, M | 2 |
| García-Cabanes, C | 2 |
| Espí, R | 1 |
| Hariton, C | 1 |
| Orts, A | 2 |
| Kulkarni, PS | 1 |
| Paterson, CA | 1 |
| Alcoriza, N | 1 |
| Rey, J | 1 |
| Daumen-Legré, V | 1 |
| Pham, T | 1 |
| Bernard, P | 1 |
| Dahan, L | 1 |
| Acquaviva, PC | 1 |
| Lafforgue, P | 1 |
| Ruiz Moreno, O | 1 |
| Ruiz Moreno, JM | 1 |
| Vélez, P | 1 |
| Alió y Sanz, J | 1 |
| Honrubia López, FM | 1 |
| Guex-Crosier, Y | 1 |
| Othenin-Girard, P | 1 |
| Deray, G | 1 |
| Le Hoang, P | 1 |
| Aupetit, B | 1 |
| Achour, A | 1 |
| Rottembourg, J | 1 |
| Baumelou, A | 1 |
1 review available for diclofenac and Uveitis
| Article | Year |
|---|---|
Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofenac; Diphos | 2000 |
2 trials available for diclofenac and Uveitis
| Article | Year |
|---|---|
A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Stud | 2013 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intra | 1992 |
11 other studies available for diclofenac and Uveitis
| Article | Year |
|---|---|
Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Fluoresc | 2018 |
Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac; | 2009 |
Uveitis in adult patients with poststreptococcal reactive arthritis: the first two cases reported associated with uveitis.
Topics: Adult; Ampicillin; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Arthritis, React | 2002 |
[Effect of topical diclofenac sodium, a non-steroidal anti-inflammatory drug, on various ocular inflammatory models in animals].
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclofenac; Eye Diseases; | 1983 |
Uveoscleritis after excessive neodymium:YAG laser posterior capsulotomy.
Topics: Aged; Cataract Extraction; Dexamethasone; Diclofenac; Female; Humans; Laser Therapy; Lens Capsule, C | 1994 |
Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cells, Cultured; Clone Cells; Diclofenac; Di | 1995 |
Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit.
Topics: Administration, Topical; Animals; Aqueous Humor; Arginine; Ciliary Body; Cyclooxygenase Inhibitors; | 1996 |
Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Diclofenac; Endotoxins; Prednisolone; Rabbits; Uveitis | 1995 |
The ocular pharmacokinetics of topical diclofenac is affected by ocular inflammation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pres | 1999 |
[Effect of tobramycin with topical diclofenac on arachidonic acid in endotoxin-induced uveitis].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Bacterial To | 2001 |
Enhancement of cyclosporine A nephrotoxicity by diclofenac.
Topics: Acute Kidney Injury; Back Pain; Cyclosporins; Diclofenac; Drug Synergism; Humans; Male; Middle Aged; | 1987 |